BBVA USA’s Medtronic MDT Stock Holding History

BBVA USA’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$10.1M	Buy	80,385 +873	+1%	+$113K	0.59%	31
2021 Q2	$9.87M	Buy	+79,512	New	+$9.98M	0.55%	35

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBVA USA's MDT Position: Q3 2021 in Review

BBVA USA increased its Medtronic (MDT) stake by 1.1% in Q3 2021, buying an estimated $113K and bringing the position to 80,385 shares worth $10.1M. The position accounts for 0.59% of the portfolio, ranked #31.

BBVA USA first reported a position in MDT in Q2 2021 and has held it in 2 quarters since. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

BBVA USA held 80,385 shares of Medtronic worth $10.1M as of Q3 2021.
BBVA USA bought 873 Medtronic shares in Q3 2021, an estimated $113K.
Medtronic made up 0.59% of BBVA USA's portfolio in Q3 2021, its #31 holding.
BBVA USA first reported a position in Medtronic in Q2 2021 and has held it in 2 quarters since.
2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.